Conditional early approval for new drug applications in Japan: Current and emerging issues

Detalles Bibliográficos
Autores principales: Tanaka, Mototsugu, Miyazawa, Haruna, Terashima, Ryohei, Ikuma, Mutsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432865/
https://www.ncbi.nlm.nih.gov/pubmed/37161871
http://dx.doi.org/10.1111/cts.13536
_version_ 1785091520499548160
author Tanaka, Mototsugu
Miyazawa, Haruna
Terashima, Ryohei
Ikuma, Mutsuhiro
author_facet Tanaka, Mototsugu
Miyazawa, Haruna
Terashima, Ryohei
Ikuma, Mutsuhiro
author_sort Tanaka, Mototsugu
collection PubMed
description
format Online
Article
Text
id pubmed-10432865
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104328652023-08-18 Conditional early approval for new drug applications in Japan: Current and emerging issues Tanaka, Mototsugu Miyazawa, Haruna Terashima, Ryohei Ikuma, Mutsuhiro Clin Transl Sci Perspectives John Wiley and Sons Inc. 2023-05-10 /pmc/articles/PMC10432865/ /pubmed/37161871 http://dx.doi.org/10.1111/cts.13536 Text en © 2023 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Perspectives
Tanaka, Mototsugu
Miyazawa, Haruna
Terashima, Ryohei
Ikuma, Mutsuhiro
Conditional early approval for new drug applications in Japan: Current and emerging issues
title Conditional early approval for new drug applications in Japan: Current and emerging issues
title_full Conditional early approval for new drug applications in Japan: Current and emerging issues
title_fullStr Conditional early approval for new drug applications in Japan: Current and emerging issues
title_full_unstemmed Conditional early approval for new drug applications in Japan: Current and emerging issues
title_short Conditional early approval for new drug applications in Japan: Current and emerging issues
title_sort conditional early approval for new drug applications in japan: current and emerging issues
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432865/
https://www.ncbi.nlm.nih.gov/pubmed/37161871
http://dx.doi.org/10.1111/cts.13536
work_keys_str_mv AT tanakamototsugu conditionalearlyapprovalfornewdrugapplicationsinjapancurrentandemergingissues
AT miyazawaharuna conditionalearlyapprovalfornewdrugapplicationsinjapancurrentandemergingissues
AT terashimaryohei conditionalearlyapprovalfornewdrugapplicationsinjapancurrentandemergingissues
AT ikumamutsuhiro conditionalearlyapprovalfornewdrugapplicationsinjapancurrentandemergingissues

Ejemplares similares